Where is MedSource located?

MedSource is headquartered in Houston, United States.

How many employees does MedSource have?

As of Jul 01, 2024, the latest employee count at MedSource is 1 - 10.

Is MedSource a funded company?

MedSource is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does MedSource rank among its competitors?

MedSource ranks 226th amongst 343 active competitors, of which 14 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Veristat, which secured $1.33M in Dec, 2021.

Who are the top competitors of MedSource?

MedSource's top competitors include TFS, Parexel and Syneos Health. Among them, Veristat secured the most recent funding round in December, 2021.

MedSource - 2026 Company Profile & Competitors

MedSource is an acquired company based in Houston (United States), founded in 1997. It operates as a Global CRO specializing in oncology, rare disease, and complex clinical trials. The company has 343 active competitors, including 14 funded and 115 that have exited. Its top competitors include companies like TFS, Parexel and Syneos Health.

Company Details

Global CRO specializing in oncology, rare disease, and complex clinical trials. It is a contract research organization providing tailored, high-quality clinical research solutions to improve outcomes and accelerate development timelines. With deep scientific and medical expertise, it empowers sponsors to overcome complexity with confidence, offering support from early planning through trial design, regulatory guidance, and post-launch insights. Services include clinical development strategy, project management, risk-based quality management, regulatory affairs, clinical trial site management, clinical monitoring, patient-centric solutions, global medical affairs, biometrics, data management, medical writing, and quality assurance. Therapeutic expertise is present in essential areas like oncology, rare disease, neurology/CNS, and complex trials. The company focuses on patient-centric clinical trials, improved patient enrollment, engagement, and retention. It offers global clinical trial delivery, helping sponsors navigate regulatory complexities and operational challenges.

Website: medsource.com
Social

Key Metrics

Founded Year

1997

Location

Houston, United States

Stage

Acquired

Ranked

226^th among 343 active competitors

Employee Count

1 - 10 as on Jul 01, 2024

Investment & Acquisitions

Datatrial

Similar Companies

TFS & 408 more

Exit Details

Acquired by Ergomed (Dec 14, 2020)

View MedSource's full profile

MedSource got acquired by Ergomed on Dec 14, 2020.

Click here to take a look at MedSource's acquisition in detail

MedSource has not raised any funding rounds yet.

MedSource's employee count trend

MedSource has 1 - 10 employees as of Jul 24. Here is MedSource's employee count trend over the years:

Uncover MedSource's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MedSource include TFS, Parexel and Syneos Health. Here is the list of Top 10 competitors of MedSource, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TFS 1996, Lund (Sweden), Acquired	A global mid-service CRO providing clinical research services	-	-	64/100
2nd	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Boston Capital Ventures, Vedanta Capital & 2 others	62/100
3rd	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Adams Street Partners, First Analysis & 1 others	61/100
4th	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	60/100
5th	Celgene 1986, Summit (United States), Acquired	Developer of therapies for treating cancer and inflammatory diseases	$45M	Piper Jaffray, BB Biotech & 12 others	56/100
6th	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, WindRose Health Investors ... & 2 others	56/100
7th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	56/100
8th	Emmes 1977, India, Acquired	Provider of outsourced CRO services	-	Behrman Capital, Apollo Investment Corporation ... & 1 others	54/100
9th	hVIVO 1998, London (United Kingdom), Public	Provider of cell based assays, field trial, and molecular services for biopharma sector	-	Woodford Investment Management, IP Group	51/100
10th	Premier Research 1989, Durham (United States), Public	Provider of clinical trial CRO services	-	alzheimerlondon.ca, Indigo Capital & 4 others	50/100
226th	MedSource 1997, Houston (United States), Acquired	Global CRO specializing in oncology, rare disease, and complex clinical trials	-	-	24/100